8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Jan 19, 2021 · 5y ago · Accession 0001558370-21-000248
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Aclaris Therapeutics, Inc.
- Ticker
- ACRS
- CIK
- 1557746
- Form type
- 8-K
- Filing date
- Jan 19, 2021
- Report date
- Jan 19, 2021
- Document
- acrs-20210119x8k.htm
- Size
- 5.2 MB